These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Patient education responsibility, specialty and administration information from the internal medicine viewpoint]. Ludwig WD Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):657-61. PubMed ID: 9527464 [TBL] [Abstract][Full Text] [Related]
4. The patient information and education initiative. Rheinstein PH; McGinnis TJ; Nightingale SL Am Fam Physician; 1995 Dec; 52(8):2377-8, 2381-2. PubMed ID: 7484726 [No Abstract] [Full Text] [Related]
5. [Patient education responsibility, specialty and administration information from the viewpoint of the pharmaceutical industry]. Granitza A Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):649-53. PubMed ID: 9527462 [TBL] [Abstract][Full Text] [Related]
6. [Education responsibility, specialty and administration information from the legal viewpoint]. Schreiber HL Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):653-7. PubMed ID: 9527463 [TBL] [Abstract][Full Text] [Related]
7. [Patient education and specialty prescription information from the psychiatric viewpoint]. Linden M Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):662-7; discussion 667-8. PubMed ID: 9527465 [No Abstract] [Full Text] [Related]
8. OBRA's counseling requirement and pharmaceutical care. Vinson MC Am J Hosp Pharm; 1993 May; 50(5):910-1. PubMed ID: 8506864 [No Abstract] [Full Text] [Related]
9. Organisations question EC changes on drug information for patients. Watson R BMJ; 2009 Mar; 338():b894. PubMed ID: 19261668 [No Abstract] [Full Text] [Related]
11. Drug companies and the public. EC proposal can be defeated. Redding D BMJ; 2009 Jan; 338():b291. PubMed ID: 19174441 [No Abstract] [Full Text] [Related]
12. [The influence of the drug legislation on drug information for the physician and patient]. Schwabe U Internist (Berl); 1980 Jun; 21(6):311-7. PubMed ID: 7005167 [No Abstract] [Full Text] [Related]
13. Compliance with Washington state's professional practice regulations: 1974 vs. 1987. Campbell RK; Baker DE; Jinks MJ; Evenson-St Amand LM Am Pharm; 1989 May; NS29(5):42-8. PubMed ID: 2729093 [No Abstract] [Full Text] [Related]
14. The pharmacist as an information provider to the patient. Apse J Can Pharm J; 1980 Jun; 113(6):191-2. PubMed ID: 10249550 [No Abstract] [Full Text] [Related]
15. Volunteering to warn of drug interactions. Williams KG Am J Health Syst Pharm; 1996 Jul; 53(14):1709-12. PubMed ID: 8827239 [No Abstract] [Full Text] [Related]
16. [Active against the pharmaceutical inferiority complex]. Heinzl S Med Monatsschr Pharm; 1988 Oct; 11(10):325. PubMed ID: 3185356 [No Abstract] [Full Text] [Related]
17. Advertising medicines to the public. George CF J R Coll Physicians Lond; 1996; 30(2):102-3. PubMed ID: 8709051 [No Abstract] [Full Text] [Related]
18. How pharmacists serve the special needs of visually-impaired patrons. Pharm Times; 1978 Jun; 44(6):60-6. PubMed ID: 10307777 [No Abstract] [Full Text] [Related]
19. Reimbursement for cognitive pharmacy services. Navarro RP Manag Care Interface; 1998 Jul; 11(7):57-9. PubMed ID: 10181571 [No Abstract] [Full Text] [Related]
20. EC, don't let drug companies give information to the public. Currie JA; Preston H; Weerapperuma S BMJ; 2009 Jan; 338():b290. PubMed ID: 19174440 [No Abstract] [Full Text] [Related] [Next] [New Search]